Patent covers machine learning techniques for ECG denoising, rhythm classification, sample-level labelling, wearable cardiac monitoring, and report generation TORONTO, ON / ACCESS Newswire / June 23, ...

Patent establishes IP across all major amyloidosis subtypes and transforms the standard 12-lead ECG into a screening tool for one of cardiology’s most underdiagnosed diseases AccurKardia, Inc., an ECG ...

Sudden cardiac death kills about 300,000 people in the U.S. each year, even though implantable defibrillators have been able to stop many lethal arrhythmias for decades. The main issue today isn’t in ...

An AI-driven app, which analyses standard electrocardiogram results for signs of atrial fibrillation, is being rolled out at hospitals in Japan with the hope of improving detection and saving lives.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...